Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
71.65
+0.89 (1.26%)
Dec 20, 2024, 4:00 PM EST - Market closed
Hologic Employees
Hologic had 6,990 employees as of September 30, 2023. The number of employees increased by 46 or 0.66% compared to the previous year.
Employees
6,990
Change (1Y)
46
Growth (1Y)
0.66%
Revenue / Employee
$576,581
Profits / Employee
$112,947
Market Cap
16.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 6,990 | 46 | 0.66% |
Sep 24, 2022 | 6,944 | 239 | 3.56% |
Sep 25, 2021 | 6,705 | 891 | 15.33% |
Sep 26, 2020 | 5,814 | -664 | -10.25% |
Sep 28, 2019 | 6,478 | 226 | 3.61% |
Sep 29, 2018 | 6,252 | 19 | 0.30% |
Sep 30, 2017 | 6,233 | 900 | 16.88% |
Sep 24, 2016 | 5,333 | 43 | 0.81% |
Sep 26, 2015 | 5,290 | -61 | -1.14% |
Sep 27, 2014 | 5,351 | -264 | -4.70% |
Sep 28, 2013 | 5,615 | -542 | -8.80% |
Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
Sep 24, 2011 | 5,019 | 799 | 18.93% |
Sep 25, 2010 | 4,220 | 261 | 6.59% |
Sep 26, 2009 | 3,959 | 26 | 0.66% |
Oct 25, 2008 | 3,933 | 353 | 9.86% |
Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
Nov 17, 2006 | 1,617 | 747 | 85.86% |
Nov 19, 2005 | 870 | 109 | 14.32% |
Nov 30, 2004 | 761 | 39 | 5.40% |
Nov 30, 2003 | 722 | -7 | -0.96% |
Nov 30, 2002 | 729 | -51 | -6.54% |
Nov 30, 2001 | 780 | -66 | -7.80% |
Nov 30, 2000 | 846 | 410 | 94.04% |
Nov 30, 1999 | 436 | 40 | 10.10% |
Nov 30, 1998 | 396 | 57 | 16.81% |
Nov 30, 1997 | 339 | 45 | 15.31% |
Nov 30, 1996 | 294 | 103 | 53.93% |
Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Baxter International | 60,000 |
Quest Diagnostics | 48,000 |
ICON Public Limited Company | 41,100 |
Viatris | 38,000 |
Align Technology | 21,610 |
Molina Healthcare | 18,000 |
Avantor | 7,570 |
Moderna | 5,600 |
HOLX News
- 3 days ago - Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC - Business Wire
- 11 days ago - Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines - Business Wire
- 12 days ago - Martin Madaus Elected to Hologic Board of Directors - Business Wire
- 12 days ago - New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence - Business Wire
- 19 days ago - Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations - Business Wire
- 26 days ago - Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024 - Business Wire
- 5 weeks ago - Hologic to Webcast Presentations at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript - Seeking Alpha